Post-pandemic healthcare trends will turn, says SEB's new biotech portfolio lead

Some of the prevailing trends in healthcare and biotech funds during the Covid-19 pandemic will reverse as the economy opens up post-pandemic, says Angelica Fatouros, portfolio manager of healthcare and biotechnology funds at SEB Investment Management.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app